By Bola Ahmed Tinubu

Nigeria should be producing far more of the medicines and medical equipment our people need. We have an established pharmaceutical industry base, highly skilled health professionals, and a substantial domestic market. Yet our dependence on imported health products remains unacceptably high, and many Nigerians still travel abroad for treatment. A country with our demographic strength should secure a greater share of production, employment, and specialist services supported by what our people spend on their health.

This dependence has broad consequences for families and for the economy. Exchange rate changes can put essential medicines beyond a household’s reach. Disruptions far from our shores can affect supplies in our hospitals. Money spent on treatment abroad sustains expertise and facilities elsewhere that we must also develop within Nigeria.

I established the Presidential Initiative for Unlocking the Healthcare Value Chain in October 2023 to address these problems. Through PVAC, we are bringing Nigerian and international investment into domestic manufacturing and healthcare services. Our objectives are to produce more essential health products, improve the care available within our country, and create quality employment across the sector.
This work forms part of the Nigeria Health Sector Renewal Investment Initiative (NHSRII), which I launched in December 2023 to give effect to the health commitments of the Renewed Hope Agenda. Its purpose is to save lives and reduce the physical and financial hardship caused by illness. We are pursuing this through stronger governance, better health services, domestic production, and greater preparedness for health emergencies. Through the accompanying compact, the Federal Government, states, and development partners committed to a common reform programme. Under this framework, investment in industry must serve the same national purpose as investment in clinics and hospitals.

Healthcare as an economic priority:

Nigeria needs more enterprises that produce, employ, and compete. Healthcare offers an opportunity to build such enterprises around a substantial and enduring demand. As we expand access to treatment, more of the expenditure involved should support businesses and skilled work within our economy.

Good health is fundamental to the prosperity we seek. It is both a cause and consequence of human capital accumulation. When illness keeps a worker at home, a child out of school, or a small business owner away from work, the cost extends beyond the clinic. A serious illness can consume years of a family’s savings.
Protecting Nigerians from those losses is part of building a more productive economy.

The government has a direct role in making that possible. Ill health undermines productivity. Outbreaks can disrupt economies. A presidential initiative enables us to bring decisions on health, finance, industry and investment into a common programme. Manufacturers should be able to plan with confidence in the rules under which they operate. Investors should find government institutions working towards the same objectives. That coordination is essential when a project requires substantial capital and several years to reach commercial scale.

We have acted on production costs:

The Executive Order I signed in June 2024 provided tax and tariff relief for specified machinery, equipment, and inputs used in local healthcare manufacturing. Between January 2025 and June 2026, the government approved more than ₦24 billion in waivers for 75 manufacturers. The purpose is to make investment and expansion more viable, with benefits that carry through to the availability and cost of essential products.

Investment in production and skills:

The manufacturing base is expanding. Ten factories producing priority health products are being established, including six in 2026. These investments cover products as varied as medicines, diagnostic tests, medical oxygen and mosquito nets. They represent productive assets around which further skills, suppliers, and investment can develop.

The mosquito-net industry provides a clear example. Following its 2024 agreement with PVAC, Vestergaard announced it will start operations at Health Textiles Nigeria from September 2026. Similarly, Harvestfield, an indigenous firm, is producing dual-ingredient nets. Production of advanced insecticide-treated nets is now underway, with Nigerian employees receiving further technical training. At full scale, the companies will produce more than ten million nets annually and employ more than 600 people.

For a country carrying a heavy malaria burden, the significance is immediate. The benefit must reach families through wider access to effective malaria protection. Resources devoted to preventing disease can also support manufacturing employment within Nigeria. As production expands, the opportunity extends to suppliers and service businesses, and the knowledge Nigerian workers acquire becomes an asset for the country. We should be able to meet more of our own needs and supply markets elsewhere in Africa.

The same ambition applies to diagnostics. Codix Bio’s agreement with the Medicines Patent Pool, supported by the World Health Organisation, enables the transfer of technology from SD Biosensor to manufacture rapid diagnostic tests in Nigeria. Partnerships like this bring technical knowledge to Nigerian enterprises and strengthen their ability to produce to international standards.

International cooperation is central to this effort. Nigeria welcomes investors who bring capital, expertise, and a long-term commitment to production here. Our market offers commercial opportunity with a strong, youthful demographic, and successful partnerships should leave the country with stronger businesses and deeper technical competence. That is how investment can contribute to economic diversification and, over time, greater export earnings. NASENI-Troment is another manufacturer using world-class technology to produce diagnostic kits locally.

Better care and greater opportunity:

From the outset, our ambition has also been to improve the care available within Nigeria. We must develop services that give Nigerians greater confidence in seeking treatment at home. Investments in advanced diagnostics, cancer care, and other specialist services can keep more healthcare expenditure within the country while creating opportunities for our clinicians and researchers. For a family facing cancer, access to treatment within Nigeria can spare them the added cost of travel abroad and long separation from loved ones.

I recognise that Nigerians will judge these reforms by the care they can obtain and afford today. New capacity takes time to reach its full effect. Domestic manufacturers still face costs that we must address, and local production must meet demanding standards of quality and competitiveness. Government support must result in better products and affordable services for Nigerians.

Our national health reform framework, pursued through a sector-wide approach, connects this industrial investment to the expansion of healthcare. As we strengthen primary care through the Basic Health Care Provision Fund and expand health insurance, we must ensure that facilities can obtain the medicines and diagnostic tests patients need. Better purchasing arrangements can turn this growing demand into predictable orders for manufacturers, supporting investment while helping public funds go further. The benefit must reach Nigerians through reliable supplies and affordable treatment, including in rural communities. Medipool, Nigeria’s first nationally approved group purchasing organisation, was established to pool demand for quality medicines and other health commodities, negotiate better prices,  and provide a more dependable market for local manufacturers.

The next stage requires sustained attention to financing, reliable demand, and the practical conditions under which enterprises operate. Announced investments must progress into production, and production must reach the facilities where Nigerians receive care. I expect the Coordinating Minister of Health and Social Welfare to sustain this work with the relevant institutions and private partners.

Nigeria’s healthcare needs should support a growing source of national prosperity. We can build businesses that serve our people, develop expertise that stays within our country and create products that compete beyond our borders. The progress already made gives us a basis to pursue that ambition with confidence. Nigerians should expect these investments to deliver dependable care, more affordable treatment and opportunities to earn a decent living.

-President Tinubu is the Commander-in-Chief, Federal Republic of Nigeria